RETROSPECTIVE COMPARISON OF PHENYTOIN AND LEVETIRACETAM AS SEIZURE PROPHYLAXIS WITH HIGH DOSE BUSULFAN DURING ALLOGENEIC STEM CELL TRANSPLANT

被引：0
|
作者：
Mathew, S. [1 ]
Harnicar, S. [1 ]
Adel, N. [1 ]
Papadopoulos, E. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2011年 / 17卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2010.12.595
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
557
引用
收藏
页码：S353 / S353
页数：1
相关论文
共 50 条
  • [31] High Dose Valaciclovir as CMV Prophylaxis in Allogeneic Haematopoietic Stem Cell Transplantation
    Douglas, Genevieve
    Yong, Michelle
    Tio, Shioyen
    Chau, Maggie
    Sasadeusz, Joe
    Slavin, Monica
    Ritchie, David
    Chee, Lynette
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 489 - 490
  • [32] The Impact of Peripheral Stem Cell As a Stem Cell Source on Gvhd for Patients Receiving Post-Transplant High Dose Cyclophosphamide As Gvhd Prophylaxis after an Allogeneic Transplant
    Shestovska, Yuliya
    Joshi, Shalina
    Fung, Henry C.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S186 - S187
  • [33] CASE CONTROL STUDY OF LEVETIRACETAM VS. FOSPHENYTOIN FOR SEIZURE PROPHYLAXIS IN CHILDREN RECEIVING BUSULFAN (BU) FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
    Skeens, M. A.
    Soni, S.
    Pai, V
    Bajwa, R.
    Pietryga, D.
    Gross, T.
    Termuhlen, A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S195 - S195
  • [34] Comparison of Short-Duration Levetiracetam with Extended-Course Phenytoin for Seizure Prophylaxis After Subarachnoid Hemorrhage
    Murphy-Human, Theresa
    Welch, Emily
    Zipfel, Gregory
    Diringer, Michael N.
    Dhar, Rajat
    WORLD NEUROSURGERY, 2011, 75 (02) : 269 - 274
  • [35] PHENYTOIN VERSUS LEVETIRACETAM FOR POST TRAUMATIC BRAIN INJURY SEIZURE PROPHYLAXIS; A RETROSPECTIVE STUDY AT A UK MAJOR TRAUMA CENTRE
    Harris, L.
    Hateley, S.
    Seemungal, B.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (03): : E31 - E31
  • [36] Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients
    Akiyama, Kana
    Kume, Tetsuo
    Fukaya, Masafumi
    Shiki, Ikue
    Enami, Terukazu
    Tatara, Raine
    Shino, Michihiro
    Ikeda, Takashi
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 82 (04) : 717 - 721
  • [37] Comparison of levetiracetam with phenytoin for the prevention of intravenous busulfan-induced seizures in hematopoietic cell transplantation recipients
    Kana Akiyama
    Tetsuo Kume
    Masafumi Fukaya
    Ikue Shiki
    Terukazu Enami
    Raine Tatara
    Michihiro Shino
    Takashi Ikeda
    Cancer Chemotherapy and Pharmacology, 2018, 82 : 717 - 721
  • [38] High-dose busulfan and the risk of pulmonary mortality after autologous stem cell transplant
    Kalaycio, Matt
    Pohlman, Brad
    Kuczkowski, Elizabeth
    Rybicki, Lisa
    Andresen, Steve
    Sobecks, Ronald
    Bolwell, Brian
    CLINICAL TRANSPLANTATION, 2006, 20 (06) : 783 - 787
  • [39] Allogeneic hematopoietic stem cell transplant after intravenous busulfan and fludarabine conditioning
    Kerbauy, Fabio R.
    Rodrigues, Morgani
    de Souza Santos, Fabio Pires
    Sobrinho, Jairo Nascimento
    Kutner, Jose Mauro
    Torres, Margareth A.
    Feitosa Ribeiro, Andreza Alice
    de Lima, Marcos
    Hamerschlak, Nelson
    LEUKEMIA & LYMPHOMA, 2011, 52 (02) : 321 - 324
  • [40] High dose acyclovir for cytomegalovirus infection prophylaxis after allogeneic stem cell transplantation
    Iannella, E.
    Lori, A. P.
    Torelli, G. F.
    Milano, F.
    Capobianchi, A.
    Lucarelli, B.
    Malandruccolo, L.
    Valle, V.
    Arleo, E.
    Martino, P.
    Foa, R.
    Gentile, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 103 - 103
12345